Early detection of chronic lung allograft dysfunction with spectral and intrabreath oscillometry.

Anne Fu, Anastasiia Vasileva, Nour Hanafi, Natalia Belousova, Joyce K Y Wu, Ella Huszti, Zoltán Hantos, Chung-Wai Chow

Abstract read

In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anne FuDepartment of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Anastasiia VasilevaDepartment of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Nour HanafiDepartment of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Natalia BelousovaThoracic Medicine and Lung Transplant Unit, St Vincent's Hospital, Sydney, Australia.

Joyce K Y WuDepartment of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Ella HusztiBiostatistics Research Unit, University Health Network, Toronto, Ontario, Canada.

Zoltán HantosDepartment of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.

Chung-Wai ChowDepartment of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic lung allograft dysfunction (CLAD) is the main obstacle to long-term survival after lung transplantation. CLAD is defined by a sustained >3-month drop in the forced expiratory volume in 1 sec (FEV Methods: This cross-sectional study analyzed 384 double lung recipients transplanted between December 2017 and January 2023. Patients who recovered within 3 months after the initial FEV Findings: At initial ≥20% FEV Conclusions: X5 differentiated between patients who developed CLAD from those whose FEV

Indexed as

chronic lung allograft dysfunctionlung transplantoscillometrypulmonary function testing

Identifiers

PMID42256236

DOI10.1016/j.jhlto.2026.100575

PMCPMC13235334

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.